Authors : Augustine Duke Onyeabochukwu; Callistus Obinna Elegbua; Henry Ifeanyi Obani; Kingsley Chukwu Episteme Obioha; Emmanuel Adeola Adekanye; Vincent Chinedu Ani; Matthew Ikechukwu Eze; Angela Adaku Elegbua

Volume/Issue : Volume 9 - 2024, Issue 6 - June

Google Scholar : https://tinyurl.com/jbdz29nt

Scribd : https://tinyurl.com/vv3cf8mw

DOI : https://doi.org/10.38124/ijisrt/IJISRT24JUN160

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background Induction of labour failure is a challenge to the parturient and her Obstetrician and is an indication for caesarean section. Misoprostol, a prostaglandin E1 analogue has been commonly used for cervical ripening and induction of labour with variable outcomes and Hyoscine N-Butyl bromide, a smooth muscle relaxant, has been well studied for its use in active phase labour. The use of both drugs for cervical ripening and labour induction may have a better prognosis than using misoprostol alone.  Objectives To compare the influence combined intramuscular Hyoscine butyl bromide and vaginal misoprostol as opposed to vaginal misoprostol alone has on the need for labour augmentation and pregnancy outcome in post-date pregnancies in Federal Medical Center Owerri, Nigeria.  Study Design A randomised double blinded clinical trial involving post-date pregnant women who received combined imtramuscular hyoscine and vaginal misoprostol and those who received vaginal misoprostol only for cervical ripening and induction of labour.  Methodology A total of 130 postdated pregnant women who satisfied the inclusion criteria were recruited for the study by systematic sampling. These were equal number of 65 participants each as case and control. They were matched for gestational age and social status. The case group received both vaginal misoprostol and intramuscular hyosine while the control received vaginal misoprostol alone for cervical ripening and induction of labour The results were analysed using SPSS version 21 with appropriate tables and figures generated.  Results The mean induction-delivery interval was (18.74±3.00 hours) in women who were given vaginal misoprostol + placebo and (16.6 ±3.00 hours) in those who received both vaginal misoprostol and intramuscular hyoscine. The median number of misoprostol inserted in the placebo group was 2 (2,3) while for hyoscine group it was 3(2,3). The mode of delivery between the hyoscine group and the control group did not show any statistically significant difference (P=0.152). However, there were 37 labour augmentation in the control group as opposed to 18 in the hyoscine group which was statistically significant (P=0.001).  Conclusion The need for labour augmentation reduces in post- date pregnancies when combined intramuscular hyoscine and vaginal misoprostol is used for cervical ripening and labour induction as opposed to vaginal misoprostol alone however, there is no difference in pregnancy outcome between the two methods.  Recommendations The use of combined intramuscular hyoscine and vaginal misoprostol for cervical ripening and induction of labour should be routinely implemented and also the use of hyoscine pessaries 7uy67/with vaginal misoprostol can be studied to see if there would be a different outcome.

Keywords : Intramuscular, Hyoscine, Vaginal Misoprostol, Cervical Ripening, Labour Augmentation, Infleunce, Combined, Pregnancy Outcome.

References :

1. Lisa D.L, Mary D.S, Samuel P, Catherine T.W, Michael A.E, Sindu K.S. Foley or Misoprostol for the Management of Induction (The ‘FOR MOMI’ trial): A four-arm randomized clinical trial. American Journal of Obstetrics & Gynecology 2016; 214 (1):S4
2. Harman JH Jr, Kim A. Current trends in cervical ripening and labour induction. Am Fam Physician 1999;60:477‑484.
3. McFarland BL, Gibson MH, O’Rear J, Harman P. A national survey of herbal preparation use by nurse‑midwives for labor stimulation. Review of the literature and recommendations for practice. J Nurse Midwifery 1999;44:205‑216
4. El‑Sherbiny MT, El‑Gharieb IH, Gwewly HA. Vaginal misoprostol for induction
5. of labour. 25 vs. 50 microg dose regimen Int J Gynaecol Obstet 2001;72:25‑30.
6. Helwick C. For Labor Induction, Two Methods Better Than One [Internet]. Medscape.2017 [cited 4 February 2016]. Available from:    http://www.medscape.com/viewarticle/858291
7. Meydanli MM, Caliskan E, Burak F, Narin MA, Atmaca R. Labour induction post‑term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol. Int Gynaecol Obstet 2003;81:249‑255.
8. Wing DA, Rahall A, Jone MM, Goodwin TM, Paul RH. Misoprostol: An effective agent for cervical ripening. Am J Obstet Gynaecol 1995;172:1811‑1816.
9. Weeks A. Clarifying the role of misoprostol in obstetrics: African Health Sciences Editorial. African Health Sciences. 2001;1(2):52-54.
10. Hanaa A, Runak TS. The effect of hyoscine N-butyl bromide on the duration of active phase of labour. Zanco J. Med. Sci, 2013;17 (3) 549-555
11. Javadi S.H.E, Ghaffari S, Movahed F, Javadi A, Mashrabi O. The effect of adding hyoscine to vaginal misoprostol on shortening time of abortion induction. African Journal of Pharmacy and Pharmacology. 2013;7(2) :46-49.
12. Trevino-Salinas, Castillo-Martin G.E, Ayuzo-del Valle C, Guzman-Lopez A, Soria-Lopez J.A, Iglesias-Benavides J.L, Ambriz-Lopez R. Effect of hyoscine butylbromide on cervical dilation during labour. Medicinia Universitaria 2015; 17(66): 30-33
13. Hadadian S, Masoumeh F. Assessing the efficacy of vaginal hyoscine butyl bromide on cervical ripening prior to intrauterine procedures. A double-blinded clinical trial. Int J Reprod Biomed. 2016; 14(11): 709-712
14. National Population Commission of Nigeria. Population and housing census of the federal republic of Nigeria,2006. Imo state priority table, volume 1. Abuja, Nigeria: NPC press; 2009: 1-5.
15. Adeniyi AA, Odukogbe AA, Olayemi A, Oladokun O, Adeniji AO, Aimakhu CO, Enakpene C. Randomization of  two dosing regimens of vaginal misoprostol for cervical ripening and labour induction in low resource setting: Nigerian Journal of Clinical Practice. 2014: 17;287-291.
16. Osaigbovoh I, Kuti  O, Badejoko O, Loto O, Olaleye A,  Effect of hyoscine butyl-bromide on the duration of active phase of labor: A randomized-controlled trial. Taiwanese Journal of Obstetrics and Gynecology. 2017; 56 (6) :725-730
17. Barau, D. , Agida, E. , Onafowokan, O. and Adebayo, F. Effect of Hyoscine Butyl Bromide on the Course of Labour. Open Journal of Obstetrics and Gynecology. 2018; 8 (12):1102-1108.
18. Girija S, Manjunath AP. Comparison of two dosing regimens of vaginal misoprostol for labour induction: a randomised controlled trial. J Turk Ger Gynecol Assoc. 2009;10(4):220-225.